{
    "root": "30c9166e-2f2c-211a-e063-6294a90a05c7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cefadroxil",
    "value": "20250320",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "D&C YELLOW NO. 10 ALUMINUM LAKE",
            "code": "CQ3XH3DET6"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FD&C BLUE NO. 2--ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "CEFADROXIL",
            "code": "280111G160",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3479"
        }
    ],
    "indications": {
        "text": "cefadroxil capsules indicated treatment patients infection caused susceptible strains designated organisms following diseases : urinary tract infections caused e. coli , p. mirabilis , klebsiellaspecies . skin skin structure infections caused staphylococci and/or streptococci . pharyngitis and/or tonsillitis caused streptococcus pyogenes ( group beta-hemolytic streptococci ) . note : penicillin intramuscular route shown effective prophylaxis rheumatic fever . cefadroxil generally effective eradication streptococci oropharynx . however , data establishing efficacy cefadroxil prophylaxis subsequent rheumatic fever available . note : culture susceptibility tests initiated prior therapy . renal function performed indicated . reduce development drug-resistant bacteria maintain effectiveness cefadroxil capsules antibacterial drugs , cefadroxil capsules used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy .",
        "doid_entities": [
            {
                "text": "pharyngitis (DOID:2275)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2275"
            },
            {
                "text": "tonsillitis (DOID:10456)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10456"
            },
            {
                "text": "rheumatic fever (DOID:1586)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1586"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "cefadroxil capsules acid-stable may administered orally without regard meals . food may helpful diminishing potential gastrointestinal complaints occasionally associated oral cephalosporin therapy .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "cefadroxil capsules usp available : 500 mg : orange opaque cap white opaque body imprinted \u201c 93 \u201d \u201c 3196 \u201d bottles : ndc 55289-589-10 bottles 10 ndc 55289-589-14 bottles 14 ndc 55289-589-20 bottles 20 ndc 55289-589-28 bottles 28 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "cefadroxil capsules contraindicated patients known allergy cephalosporin group antibiotics .",
    "indications_original": "Cefadroxil capsules are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases:\n                  Urinary tract infections caused by\n \n  E. coli,\n \n  P. mirabilis, and\n \n  Klebsiellaspecies.\n\n \n                  Skin and skin structure infections caused by staphylococci and/or streptococci.\n                  Pharyngitis and/or tonsillitis caused by\n \n  Streptococcus pyogenes(Group A beta-hemolytic streptococci).\n\n \n                  \n                     Note:Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Cefadroxil is generally effective in the eradication of streptococci from the oropharynx. However, data establishing the efficacy of cefadroxil for the prophylaxis of subsequent rheumatic fever are not available.\n\n \n                  \n                     Note:Culture and susceptibility tests should be initiated prior to and during therapy. Renal function studies should be performed when indicated.\n\n \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefadroxil capsules and other antibacterial drugs, cefadroxil capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications_original": "Cefadroxil capsules are acid-stable and may be administered orally without regard to meals. Administration with food may be helpful in diminishing potential gastrointestinal complaints occasionally associated with oral cephalosporin therapy.",
    "warningsAndPrecautions_original": "Cefadroxil Capsules USP are available as:\n                  500 mg: orange opaque cap and white opaque body imprinted with \u201c93\u201d and \u201c3196\u201d in bottles of:\n                  NDC 55289-589-10 Bottles of 10\n                  NDC 55289-589-14 Bottles of 14\n                  NDC 55289-589-20 Bottles of 20\n                  NDC 55289-589-28 Bottles of 28\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Cefadroxil capsules are contraindicated in patients with known allergy to the cephalosporin group of antibiotics.",
    "drug": [
        {
            "name": "Cefadroxil",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3479"
        }
    ]
}